Localization of [3H]nicotine, [3H]cytisine, [3H]epibatidine, and [125I]α-bungarotoxin binding sites in the brain of Macaca mulatta

Journal of Comparative Neurology

Volumn 461, Issue 1, 2003, Pages 49-60

  Han, Zhi Yan ^a   Zoli, Michele ^b   Cardona, Ana ^a   Bourgeois, Jean Pierre ^a   Changeux, Jean Pierre ^a   Le Novère, Nicolas ^a  

^a INSTITUT PASTEUR   (France)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Cerebral cortex; Nicotinic acetylcholine receptors; Nicotinic ligands

Indexed keywords

ALPHA BUNGAROTOXIN I 125; CYTISINE; EPIBATIDINE; MESSENGER RNA; NICOTINE; ALKALOID; ALPHA-BUNGAROTOXIN RECEPTOR; AZOCINE DERIVATIVE; BUNGAROTOXIN RECEPTOR; FUSED HETEROCYCLIC RINGS; NICOTINIC AGENT; NICOTINIC RECEPTOR; PYRIDINE DERIVATIVE; QUINOLIZINE DERIVATIVE;

AMYGDALOID NUCLEUS; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BINDING SITE; DENTATE GYRUS; HIPPOCAMPUS; MACACA; MESENCEPHALON; NONHUMAN; PRIORITY JOURNAL; SUBICULUM; THALAMUS NUCLEUS; ANIMAL; BRAIN; BRAIN MAPPING; DIENCEPHALON; DRUG ANTAGONISM; DRUG POTENTIATION; MALE; METABOLISM; METHODOLOGY; RADIOASSAY; TELENCEPHALON; TISSUE DISTRIBUTION;

ALKALOIDS; ANIMALS; AUTORADIOGRAPHY; AZOCINES; BICYCLO COMPOUNDS, HETEROCYCLIC; BINDING SITES; BRAIN; BRAIN MAPPING; DIENCEPHALON; MACACA MULATTA; MALE; MESENCEPHALON; NICOTINE; NICOTINIC AGONISTS; PYRIDINES; QUINOLIZINES; RADIOLIGAND ASSAY; RECEPTORS, NICOTINIC; TELENCEPHALON; TISSUE DISTRIBUTION;

EID: 0038249139     PISSN: 00219967     EISSN: None     Source Type: Journal    
DOI: 10.1002/cne.10659     Document Type: Article

References (70)

1. Adler LE, Olincy A, Waldo M, Harris JG, Griffith J, Stevens K, Flach K, Nagamoto H, Bickford P, Leonard S, Freedman R. 1998. Schizophrenia, sensory gating, and nicotinic receptors. Schizophr Bull 24:189-202.
2. Alonso JR, Amaral DG. 1995. Cholinergic innervation of the primate hippocampal formation. I. Distribution of choline acetyltransferase immunoreactivity in the Macaca fascicularis and Macaca mulatta monkeys. J Comp Neurol 355:135-170.
3. Alonso JR, Hoi Sang U, Amaral DG. 1996. Cholinergic innervation of the primate hippocampal formation: II. Effects of fimbria/fornix transection. J Comp Neurol 375:527-551.
4. Anand R, Peng X, Ballesta JJ, Lindstrom J. 1993. Pharmacological characterization of α-bungarotoxin-sensitive acetylcholine receptors immunoisolated from chick retina: contrasting properties of α7 and α8 subunit-containing subtypes. Mol Pharmacol 44:1046-1050.
5. Boulter J, Connolly J, Deneris E, Goldman D, Heinemann S, Patrick J. 1987. Functionnal expression of two neuronal nicotinic acetylcholine receptors from cDNA clones identifies a gene family. Proc Natl Acad Sci USA 84:7763-7767.
6. 125I]alpha-bungarotoxin binding in human postmortem brain. J Comp Neurol 387:385-398.
7. Broides RS, Robertson RT, Leslie FM. 1996. Regulation of α7 nicotinic acetylcholine receptors in the developing rat somatosensory cortex by thalamocortical afferents. J Neurosci 16:2956-2971.
8. Champtiaux N, Han Z-Y, Bessis A, Rossi FM, Zoli M, Marubio L, McIntosh M, Changeux J-P. 2002. Distribution and pharmacology of α6-containing nicotinic acetylcholine receptors analysed with mutant mice. J Neurosci 22:1208-1217.
9. Chen DN, Patrick J. 1997. The α-bungarotoxin-binding nicotinic acetylcholine receptor from rat brain contains only the α7 subunit. J Biol Chem 272:24024-24029.
10. Cimino M, Marini P, Fornasari D, Cattabeni F, Clementi F. 1992. Distribution of nicotinic receptors in cynomolgus monkey brain and ganglia - localization of alpha3 subunit messenger RNA, alphabungarotoxin and nicotine binding sites. Neuroscience 51:77-86.
11. Clarke PBS, Pert CB, Pert A. 1984. Autoradiographic distribution of nicotinic receptors in rat brain. Brain Res 323:390-395.
12. 125I]α-bungarotoxin. J Neurosci 5:1307-1315.
13. Corringer PJ, Le Novère N, Changeux J-P. 2000. Nicotinic receptors at the amino acid level. Annu Rev Pharmacol Toxicol 40:431-458.
14. Court J, Spurden D, Lloyd S, Mckeith I, Ballard C, Cairns N, Kerwin R, Perry R, Perry E. 1999. Neuronal nicotinic receptors in dementia with Lewy bodies and schizophrenia: a-bungarotoxin and nicotine binding in the thalamus. J Neurochem 73:1590-1597.
15. Court JA, Martin-Ruiz C, Graham A, Perry E. 2000a. Nicotinic receptors in human brain: topography and pathology. J Chem Neuroanat 20:281-298.
16. Court JA, Piggott MA, Lloyd S, Cookson N, Ballard CG, McKeith IG, Mckeith IG, Perry RH, Perry EK. 2000b. Nicotine binding in human striatum: elevation on schizophrenia and reductions in dementia with Lewy bodies, Parkinson's disease and Alzheimer's disease and in relation to neuroleptic medication. Neuroscience 98:79-87.
17. Court J, Martin-Ruiz C, Piggott M, Spurden D, Griffiths M, Perry E. 2001. Nicotinic receptor abnormalities in Alzheimer's disease. Biol Psychiatry 49:175-184.
18. Couturier S, Bertrand D, Matter J-M, Hernandez M-C, Bertrand S, Millar N, Valera S, Barkas T, Ballivet M. 1990. A neuronal nicotinic acetylcholine receptor subunit (α7) is developmentally regulated and forms homooligomeric channel blocked by α-Bgt. Neuron 5:847-856.
19. 125I-ligand receptor binding and pharmacological studies. Histochem J 28:801-809.
20. De Fusco M, Becchetti A, Patrignani A, Annesi G, Gambardella A, Quattrone A, Ballabio A, Wanke E, Casari G. 2000. The nicotinic receptor β2 subunit is mutant in nocturnal frontal lobe epilepsy. Nat Genet 26: 275-276.
21. Dehaene S, Kerszberg M, Changeux J-P. 1998. A neuronal model of a global workspace in effortful cognitive task. Proc Natl Acad Sci USA 95:14529-14534.
22. Di Chiara G. 2000. Role of dopamine in the behavioural actions of nicotine related to addiction. Eur J Pharmacol 393:295-314.
23. Freedman R, Hall M, Adeler LE, Leonard S. 1995. Evidence in postmortem brain tissue doe decreased number of hippocampal nicotinic receptors in Schizophrenia. Biol Psychiatry 38:22-33.
24. Freedman R, Coon H, Myles-Worsley M, Orr-Urtreger A, Olincy A, Davis A, Polymeropoulos M, Holik J, Hopkins J, Hoff M, Rosenthal J, Waldo MC, Reimherr F, Wender P, Yaw J, Young DA, Breese CR, Adams C, Patterson D, Adler LE, Kruglyak L, Leonard S, Byerley W. 1997. Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus. Proc Natl Acad Sci USA 94:587-592.
25. 125I]α-bungarotoxin binding marks primary sensory areas of developing rat neocortex. Brain Res 501:223-234.
26. Gopalakrishnan M, Monteggia LM, Anderson DJ, Molinari EJ, Piattoni-Kaplan M, Donnelly-Roberts D, Arneric SP, Sullivan JP. 1996. Stable expression, pharmacologic properties and regulation of the human neuronal nicotinic acetylcholine α4β2 receptor. J Pharmacol Exp Ther 276:289-297.
27. Gotti C, Fornasari D, Clementi F. 1997. Human neuronal nicotinic receptors. Neurobiology 53:199-237.
28. Han Z-Y, Le Novère N, Zoli M, Hill JA Jr, Champtiaux N, Changeux J-P. 2000. Localization of nAChR subunit mRNA in the brain of Macaca mulatta. Eur J Neurosci 12:3664-3674.
29. 3H]cytisine. Neuroscience 62:929-944.
30. 3H]nicotine. Acta Physiol Scand 132:1-14.
31. Kageyama GH, Gallivan ME, Gallardo KA, Robertson RT. 1990. Relationships between patterns of acetylcholinesterase activity and geniculocortical terminal fields in developing and mature rat visual cortex. Brain Res Dev Brain Res 53:139-144.
32. Karlin A. 2002. Emerging structure of the nicotinic acetylcholine receptors. Nat Rev Neurosci 3:102-114.
33. Le Novère N, Corringer P-J, Changeux J-P. 2002. The diversity of subunit composition in nAChRs: evolutionary origins, physiological and pharmacological consequences. J Neurobiol 53:447-456.
34. Léna C, Changeux J-P. 1997. Pathological mutations of nicotinic receptors and nicotine-based therapies for brain desorders. Curr Opin Neurobiol 7:674-682.
35. Levin E, Simon B. 1998. Nicotinic acetylcholine involvement in cognitive function in animals. Psychopharmacology 138:217-230.
36. Marubio LM, Arroyo-Jimenez MdM, Cordero-Erausquin M, Léna C, Le Novère N, de Kerchove d'Exaerde A, Huchet M, Damaj MI, Changeux J-P. 1999. Reduced antinociception in mice lacking neuronal nicotinic receptor subunits. Nature 398:805-810.
37. Morel A, Garraghty PE, Kaas JH. 1993. Tonotopic organization, architectonic fields, and connections of auditory cortex in macaque monkeys. J Comp Neurol 335:437-459.
38. Morris R, Petrides M, Pandya DN. 1999. Architecture and connections of retrosplenial area 30 in the rhesus monkey (Macaca mulatta). Eur J Neurosci 11:2506-2518.
39. Orr-Urtreger A, Goldner FM, Saeki M, Lorenzo I, Goldberg L, De Biasi M, Dani JA, Patrick JW, Beaudet AL. 1997. Mice deficient in the alpha7 neuronal nicotinic acetylcholine receptor lack alpha-bungarotoxin binding sites and hippocampal fast nicotinic currents. J Neurosci 17: 9165-9171.
40. Parker MJ, Beck A, Luetje CW. 1998. Neuronal nicotinic receptor β2 and β4 subunits confer large differences in agonist binding affinity. Mol Pharmacol 54:1132-1139.
41. Pauly JR, Stitzel JA, Marks MJ, Collins AC. 1989. An autoradiographic analysis of cholinergic receptors in mouse brain. Brain Res Bull 22: 453-459.
42. Paxinos G, Huang XF, Toga AW. 2000. The rhesus monkey brain. New York: Academic Press.
43. 3H]epibatidine labels nicotinic receptors in rat brain: an autoradiographic study. J Pharmacol Exp Ther 275:1030-1034.
44. 3H]nicotine binding in human cortex: relative abundance in subicular complex. J Chem Neuroanat 5:399-405.
45. Perry EK, Morris CM, Court JA, Cheng A, Fairbairn AF, McKeith IG, Irving D, Brown A, Perry RH. 1995. Alteration in nicotine binding sites in Parkinson's disease: possible index of early neuropathology. Neuroscience 64:385-395.
46. Picciotto MR, Zoli M, Léna C, Bessis A, Lallemand Y, Le Novère N, Vincent P, Merlo-Pich E, Brulet P, Changeux J-P. 1995. Abnormal avoidance learning in mice lacking functional high-affinity nicotine receptor in the brain. Nature 374:65-67.
47. Picciotto MR, Zoli M, Rimondini R, Léna C, Marubio LM, Merlo-Pich E, Fuxe K, Changeux J-P. 1998. Acetylcholine receptors containing the β2 subunit are involved in the reinforcing properties of nicotine. Nature 391:173-177.
48. Quik M, Polonskaya Y, Gillespie A, Jakowec M, Lloyd GK, Langston JW. 2000a. Localization of nicotinic receptor subunit mRNAs in monkey brain by in situ hybridization. J Comp Neurol 425:58-69.
49. Quik M, Polonskaya Y, Gillespie A, Lloyd GK, Langston JW. 2000b. Differential alteration in nicotinic receptor α6 and β3 subunit messenger RNAs in monkey substantia nigra after nigrostriatal degeneration. Neuroscience 100:63-72.
50. Rogers S, Gahring L, Collins A, Marks M. 1998. Age-related changes in neuronal nicotinic acetylcholine receptor subunit alpha4 expression are modified by long-term nicotine administration. J Neurosci 18:4825-4832.
51. Role LW, Berg DK. 1996. Nicotinic receptors in the development and modulation of CNS synapses. Neuron 16:1077-1085.
52. Ross SA, Wong JY, Clifford JJ, Kinsella A, Massalas JS, Horne MK, Scheffer IE, Kola I, Waddington JL, Berkovic SF, Drago J. 2000. Phenotypic characterisation of an α4 neuronal nicotinic acetylcholine receptor subunit knock-out mouse. J Neurosci 20:6431-6441.
53. Rubboli F, Court J, Sala C, Morris C, Chini B, Perry E, Clementi F. 1994. Distribution of nicotinic receptors in the human hippocampus and thalamus. Eur J Neurosci 6:1596-1604.
54. Schilstrom B, Fagerquist, MV, Zhang X, Hertel P, Panagis G, Nomikos G, Svensson T. 2000. Putative role of presynaptic alpha7* nicotinic receptors in nicotine stimulated increases of extracellular levels of glutamate and aspartate in the ventral tegmental area. Synapse 38:375-383.
55. Schoepfer R, Conroy WG, Whiting P, Gore M, Lindstrom J. 1990. Brain alpha-bungarotoxin binding protein cDNAs and mAbs reveal subtypes of this branch of the ligand-gated ion channel gene superfamily. Neuron 5:35-48.
56. Séguéla P, Wadiche J, Dineley-Miller K, Dani J, Patrick JW. 1993. Molecular cloning, functional properties, and distribution of rat brain alpha7: a nicotinic cation channel highly permeable to calcium. J Neurosci 13:596-604.
57. 3H]epibatidine in vitro autoradiography. Neuroscience 85:1121-1133.
58. 3H]epibatidine binding in relation to vesicular acetylcholine transport sites in the temporal cortex in Alzheimer's disease. Neuroscience 94:685-696.
59. 125I]α-bungarotoxin binding. J Chem Neuroanat 13:105-113.
60. Stauderman KA, Mahaffy LS, Akong M, Veliçelebi G, Chavez-noriega LE, Crona JH, Johnson EC, Elliott KJ, Gillespie A, Reid RT, Adams P, Harpold MM, Corey-Naeve J. 1998. Characterization of human recombinant neuronal nicotinic acetylcholine receptor subunit combinations α2β4, α3β4 and α4β4 stably expressed in HEK293 Cells. J Pharmacol Exp Ther 284:777-789.
61. Steinlein O, Mulley J, Propping P, Wallace R, Phillips H, Sutherland G, Scheffer I, Berkovic S. 1995. A missense mutation in the neuronal nicotinic acetylcholine receptor alpha 4 subunit is associated with autosomal dominant nocturnal frontal lobe epilepsy. Nat Genet 11: 201-203.
62. Steinlein OK, Magnusson A, Stoodt J, Bertrand S, Weiland S, Berkovic S, Nakken K, Propping P, Bertrand D. 1997. An insertion mutation of the CHRNA4 gene in a family with autosomal dominant nocturnal frontal lobe epilepsy. Hum Mol Genet 6:943-947.
63. Szabo J, Cowan WM. 1984. A stereotaxic atlas of the brain of the cynomologous monkey (Macaca fascicularis). J Comp Neurol 222:265-300.
64. Wada E, Wada K, Boulter J, Deneris E, Heinemann S, Patrick J, Swaanson LW. 1989. Distribution of alpha2, alpha3, alpha4, and beta2 neuronal nicotinic receptor subunit mRNAs in the central nervous system: a hybridization histochemical study in the rat. J Comp Neurol 184:314-335.
65. Wang F, Gerzanich V, Wells GB, Anand R, Peng X. 1996. Assembly of human neuronal nicotinic receptor alpha5 subunits with alpha3, beta2 and beta4. J Biol Chem 271:17656-17665.
66. 3H]methyllycaconitine in the mouse brain. Eur J Neurosci 11:2689-2696.
67. Whiting P, Schoepfer R, Lindstrom J, Priestley T. 1991. Structural and pharmacological characterization of the major brain nicotinic acetylcholine receptor subtype stably expressed in mouse fibroblast. Mol Pharmacol 40:463-472.
68. Zoli M, Le Novère N, Hill JA, Changeux J-P. 1995. Developmental regulation of nicotinic ACh receptor subunit mRNAs in the rat central and peripheral nervous systems. J Neurosci 15:1912-1939.
69. Zoli M, Léna C, Picciotto MR, Changeux J-P. 1998. Identification of four classes of brain nicotinic receptors using β2 mutant mice. J Neurosci 18:4461-4472.
70. Zoli M, Picciotto MR, Ferrari R, Cocchi D, Changeux J-P. 1999. Increased neurodegeneration during ageing in mice lacking high-affinity nicotine receptors. EMBO J 18:1235-1244.